Hyderabad Telangana, India

Ravikanth Dupud


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Journey of Ravikanth Dupud

Introduction

Ravikanth Dupud is an accomplished inventor based in Hyderabad, Telangana, India. He specializes in the pharmaceutical industry and has made significant contributions through his innovative ideas and patents. His work primarily focuses on enhancing the purification processes of important pharmaceutical compounds.

Latest Patents

Ravikanth holds a patent for his groundbreaking invention titled "Process for the preparation of lifitegrast." This patent includes the dibenzylamine salt of Lifitegrast and the diphenylamine salt of Lifitegrast. His invention addresses the purification process of Lifitegrast, presenting an effective methodology for preparing this vital compound that has notable implications in the medical field.

Career Highlights

Currently, Ravikanth Dupud is associated with Aurobindo Pharma Limited, a prominent player in the pharmaceutical sector. His expertise in the field has allowed him to create innovative solutions that enhance the quality and efficacy of medications. His commitment to research and development has greatly benefited the company's product offerings.

Collaborations

Throughout his career, Ravikanth has collaborated with talented professionals, including Praveen Kumar Neela and Guruswamy Batthini. These collaborations have nurtured a creative environment where new ideas flourish, contributing to significant advancements in pharmaceutical sciences.

Conclusion

Ravikanth Dupud exemplifies the spirit of innovation and dedication in the field of pharmaceuticals. His contributions, particularly the patent on Lifitegrast preparation, signify a step forward in improving medical treatments. As he continues to work with Aurobindo Pharma Limited and collaborate with his colleagues, the potential for further advancements and innovations in this field remains promising.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…